> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 90% of Public Comments at Panel Meetings Supported Approval: Study
- URL: https://www.fdaweb.com/90-of-public-comments-at-panel-meetings-supported-approval-study/
- Published: 2026-11-09T17:07:00.000Z
- Updated: 2026-11-09T17:07:00.000Z
- Author: David McFarland
- Tags: FDA Policy/General

More than 90% of public comments submitted during five FDA drug advisory committee reviews favored approval of the products under consideration, according to a new study examining public participation in the agency's regulatory decision-making process.

The [study](https://link.springer.com/article/10.1007/s43441-026-01074-z?ref=fdaweb.com), published 11/7 in *Therapeutic Innovation & Regulatory Science*, analyzed 600 public comments associated with five FDA advisory committee meetings held between 2020 and 2024\. The meetings concerned treatments for amyotrophic lateral sclerosis (ALS), type 1 diabetes, post-traumatic stress disorder (PTSD), Duchenne muscular dystrophy and pediatric neuroblastoma.

Researchers found that 90.2% of comments favored approval, while just 1.3% opposed it. Caregivers and immediate family members accounted for 31.5% of participants, followed by patients at 17.2%.

The findings highlight the prominence of patients and caregivers in FDA advisory committee proceedings, particularly for serious diseases with limited treatment options.